Аналитика на 10 июня

Спайдер почти не изменяется перед открытием торгов на NYSE.  

• Европейские индексы изменяются разнонаправленно.

SPY (внутридневной график)  боковое движение   на   премаркете. Сопротивление: 165.00  Поддержка: 164.50
 
ПремаркетNYSE/NASDAQ:
Gapping up:
In reaction to strong earnings/guidance/comps: TPLM +3.1%, MCD +2.3%.
 
Select financial related names showing strength: DB +2%, RBS +1%, BAC +0.9%.
 
A few Japan related names showing strength: TM +3.4%, MTU +2.8%, SNE +2.2%, HMC +1%.
 
Other news: APRI +13.3% (receives European approval for Vitaros for the treatment of erectile dysfunction), CSIQ +6.8% (signs CAD310 mln EPC agreement for the construction of a 130 MW DC solar power plant in Ontario), TRQ +4.1% (still checking), BLRX +3% (enters into collaboration to develop and commercialize Hepatitis C Drug with CTTQ, a Chinese Pharma Company for Liver Disease Therapeutics), MTG +2.9% (releases May 2013 operating statistics; reports primary new insurance written of $2.8 bln ($2.4 bln in April); reports Ending Primary Delinquent Inventory of 119.1K (126.6K in April), FL +2.5% (positive mention in Barrons), GILD +2.3% ( announces U.S. FDA Priority Review designation for sofosbuvir for the treatment of hepatitis C ), SAP +1.5% (may be attributed to exec comments related to potential expansion via acquisitions), GMCR +1.3% (still checking), RCL +1.1% (still checking), BBRY +1% (still checking), AAPL +0.7% (Apple is expected to introduce new iOS software and a music service at WWDC today, according to reports).

 
Analyst comments: FMS +2.1% (upgraded to Overweight from Equal Weight at Barclays), FB +2.1% (upgraded to Buy at Stifel), MON +1.8% (upgraded to Outperform from Neutral at Macquarie), NOK +1.7% (may be attributed to tgt increase at HSBC), IMAX +1.5% (upgraded to Buy from Neutral at B. Riley), MMM +0.7% (target to $128 from $120 at Jefferies)
Gapping down:
M&A news:OMX -14% (OfficeMax sets July 10 as date for special shareholder meeting to vote on pending ODP Merger).
 
Other news:DVAX -26.3% (reports feedback from FDA meeting regarding HEPLISAV biologic license application; safety database does indeed need additional subjects), XIDE -25% ( files voluntary Chapter 11 petition to restructure U.S. operations and strengthen balance sheet), HK -3.4% (provides operational update; says The Company is currently operating 17 rigs across its holdings and is producing approximately 30,000 barrels of oil equivalent per day), TSLA -2.4% (following cautious mention in Barron's), GTAT -1.9% (files shelf registration statement).
 
Analyst comments:TWI -4.3% (downgraded to Market Perform from Outperform at William Blair, downgraded to Neutral from Buy at Janney, downgraded to Hold from Buy at Jefferies ), IRE -2.1% (downgraded to Sell from Neutral at Goldman), LEN -0.8% (downgraded to Neutral from Overweight at JP Morgan ), MS -0.7% (downgraded to Perform at Oppenheimer)
Торговые идеи NYSEи NASDAQ:
MCD-  шорт ниже 100.00
GILD– лонг при закреплении выше 54.00
OMX– смотрим на уровень 11.00, ниже него открываем короткие позиции, выше – длинные.
TWI– шорт при удержании уровня 20.00
 
Оригинал статьи:http://shark-traders.com/blog/analitika-na-10-iyunya/